Lexeo Therapeutics director Tobin Schilke files initial beneficial ownership statement
LXEO•Lexeo Therapeutics director Tobin Schilke filed an initial beneficial ownership statement on Nov. 17, 2026.
1. Ownership filing
Tobin Schilke, a director of Lexeo Therapeutics, filed an initial statement of beneficial ownership on Nov. 17, 2026.




